El Salvador vs Low income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)

El Salvador
98.0%
in 2025
Low income (World Bank)
68.0%
in 2025
El Salvador rank
11th
Low income (World Bank) rank
8th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • El Salvador
  • Low income (World Bank)
020406080100200820162025

How they compare

El Salvador currently reports 98.0% against 68.0% in Low income (World Bank), a difference of 30.0%.

That makes El Salvador's figure about 1.4 times Low income (World Bank)'s.

The two have swapped places 1 time across 18 shared years of data; in 2008 it was Low income (World Bank) ahead.

El Salvador ranks 11th and Low income (World Bank) ranks 8th of 194 countries.

El Salvador has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade El Salvador Low income (World Bank) Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 91.0% 44.8% 46.2% El Salvador
2020s 94.7% 64.0% 30.7% El Salvador

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), El Salvador or Low income (World Bank)?
El Salvador, at 98.0% against 68.0% in Low income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between El Salvador and Low income (World Bank)?
30.0%, with El Salvador ahead.
How many years of comparable data are there for El Salvador and Low income (World Bank)?
18 years are reported by both, from 2008 to 2025.
How do El Salvador and Low income (World Bank) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
El Salvador ranks 11th and Low income (World Bank) ranks 8th of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

El Salvador vs Low income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 06 September 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/el-salvador/low-income-world-bank/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/el-salvador/low-income-world-bank/">El Salvador vs Low income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed